Department of Biochemistry and Molecular Biology, Medical University of Lublin, 20-093 Lublin, Poland.
Endocrinology. 2024 Apr 29;165(6). doi: 10.1210/endocr/bqae052.
The glycoprotein receptors, members of the large G protein-coupled receptor family, are characterized by a large extracellular domains responsible for binding their glycoprotein hormones. Hormone-receptor interactions are traditionally analyzed by ligand-binding assays, most often using radiolabeling but also by thermal shift assays. Despite their high sensitivity, these assays require appropriate laboratory conditions and, often, purified plasma cell membranes, which do not provide information on receptor localization or activity because the assays typically focus on measuring binding only. Here, we apply bioluminescence resonance energy transfer in living cells to determine hormone-receptor interactions between a Gaussia luciferase (Gluc)-luteinizing hormone/chorionic gonadotropin receptor (LHCGR) fusion and its ligands (human chorionic gonadotropin or LH) fused to the enhanced green fluorescent protein. The Gluc-LHCGR, as well as other Gluc-G protein-coupled receptors such as the somatostatin and the C-X-C motif chemokine receptors, is expressed on the plasma membrane, where luminescence activity is equal to membrane receptor expression, and is fully functional. The chimeric enhanced green fluorescent protein-ligands are properly secreted from cells and able to bind and activate the wild-type LHCGR as well as the Gluc-LHCGR. Finally, bioluminescence resonance energy transfer was used to determine the interactions between clinically relevant mutations of the hormones and the LHCGR that show that this bioassay provides a fast and effective, safe, and cost-efficient tool to assist the molecular characterization of mutations in either the receptor or ligand and that it is compatible with downstream cellular assays to determine receptor activation/function.
糖蛋白受体是大 G 蛋白偶联受体家族的成员,其特点是具有负责结合其糖蛋白激素的大型细胞外结构域。激素-受体相互作用传统上通过配体结合测定来分析,最常用的是放射性标记,但也可以通过热移位测定来分析。尽管这些测定具有很高的灵敏度,但它们需要适当的实验室条件,并且通常需要纯化的浆细胞瘤膜,因为这些测定通常仅侧重于测量结合,而不能提供受体定位或活性的信息。在这里,我们在活细胞中应用生物发光共振能量转移来确定 Gaussia 荧光素(Gluc)-促黄体生成素/绒毛膜促性腺激素受体(LHCGR)融合与其融合的配体(人绒毛膜促性腺激素或 LH)之间的激素-受体相互作用。Gluc-LHCGR 以及其他 Gluc-G 蛋白偶联受体(如生长抑素和 C-X-C 基序趋化因子受体)表达在质膜上,在质膜上,发光活性等于膜受体表达,并且是完全功能性的。嵌合增强型绿色荧光蛋白配体可从细胞中正确分泌,并能够结合并激活野生型 LHCGR 以及 Gluc-LHCGR。最后,生物发光共振能量转移用于确定激素和 LHCGR 的临床相关突变之间的相互作用,表明该生物测定法提供了一种快速,有效,安全且具有成本效益的工具,可辅助受体或配体中突变的分子特征,并且与下游细胞测定法兼容以确定受体的激活/功能。